Skip to main content

and
  1. No Access

    Article

    Development of a UHPLC-MS method for inhibitor screening against α-L-1,3-fucosidase

    α-L-Fucosidase (AFU) is a promising therapeutic target for the treatment of inflammation, cancer, cystic fibrosis, and fucosidosis. Some of the existing analytical methods for the assessment of AFU activity ar...

    Tangrong Liu, Ruonan Liu, Li Zhu, Xuan Zou in Analytical and Bioanalytical Chemistry (2019)